Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paxil CR in MDD patients intolerant to other SSRIs/SNRIs
NCT00049972Phase 4Completed
- Sponsor
- GSK
- Start
- Sep 2002
- Primary completion
- Sep 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of paroxetine in major depressive disorder (MDD), sponsored by GSK. Started Sep 2002; status: completed.
02
Drugs
paroxetine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT00049972.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00049972.